BioCorRx, Inc. Featured as Exhibitor at the eMoneyShow, San Francisco, CA

Los Angeles, Aug. 21, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program, will exhibit at the eMoneyShow in San Francisco, CA August 21-23, 2014. The show will broadcast live online as more than forty of the world's top finance experts share profitable strategies for investing and trading in topping markets. The eMoneyShow gives investors all over the globe front-row access to key note speakers, workshops, panel discussions and more. "We are pleased at the opportunity to participate in a show featuring so many prestigious speakers and finance experts alongside a large group of well-respected companies," states BioCorRx, Inc. CEO Kent Emry.

Investors interested in participating in the show must complete the free registration and login online at the eMoneyShow website. The BioCorRx, Inc. virtual booth featuring video feed as well as company information can be found by logging in and visiting the Exhibit Hall mainpage. The show will broadcast live online August 21-23 and will then be available on demand through September 13, 2014 at the eMoneyShow website. Investors in and around the San Francisco Bay area can attend the show in person and stop by the BioCorRx, Inc. booth to meet company executives Kent Emry, Lourdes Felix, and Brady Granier as well as company founder Neil Muller.

Visit the BioCorRx, Inc. eBooth by logging in here. Complete show details can be found here.

Visit BioCorRx, Inc.'s new investor relations website to receive the most up to date company information.

Click here to view Recent National Television Media on the BioCorRx YouTube Channel

Click here for company Facebook page for more stories and media coverage

About BioCorRx, Inc.

BioCorRx, Inc. (OTCQB: BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX, visit

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

CONTACT: Investor Relations, Inc. 512-267-2430